ADVM Adverum Biotechnologies
- 4.2700
- -0.2500-5.53%
- 4.2700
- 0.00000.00%
Adverum Biotechnologies News
Adverum Biotechnologies | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Adverum Biotechnologies | SCHEDULE 13G: Others
Adverum Biotechnologies | 8-K: Current report
Adverum Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Vivo Opportunity Fund Holdings, L.P.(1.1%),Vivo Opportunity, LLC(1.1%)
Adverum Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Logos Global Management LP(2.0%),Logos Global Management GP LLC(2.0%), etc.
Adverum Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(0%),Commodore Capital Master LP(0%)
Adverum Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(1.128%),Abigail P. Johnson(1.128%)
Adverum Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(7.2%)
Adverum Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Morgan Stanley(0.4%),Morgan Stanley Capital Services LLC(0.1%)
Adverum Biotechnologies | 10-Q: Q3 2024 Earnings Report
Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports Third Quarter 2024 Financial Results, Provides Corporate Highlights and Updates Anticipated Milestones
Adverum Biotechnologies | SCHEDULE 13G: Others
Adverum Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Augustus Stern, MD(5.37%)
Adverum Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Principia Wealth Advisory, LLC, EIN: 27-1545452(5.07%)
Adverum Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(7.2%)
Adverum Biotechnologies | 10-Q: Q2 2024 Earnings Report
Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corporate Highlights
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Soparkar Peter
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Seyedkazemi Setareh
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Rubinstein Linda M
No Data